Piper Sandler Initiates Coverage on Marvell with $270 Price Target

The news is not directly related to NVDA; Piper Sandler's initiation of coverage on Marvell (MRVL) may have a limited sector impact on NVDA. NVDA's technical picture is weak: the price is below the SMA20 and SMA50, RSI at 39 indicates weakness but not oversold, and MACD is in negative territory. Therefore, the news is not expected to create a clear direction for NVDA. In the short term, the movement around $219 and the resistance zone at $221-224 should be monitored. The overall trend is under downward pressure, but there is no clear news-driven catalyst.

The news headline does not directly target AVGO, but rather a competitor in the sector (Marvell). Therefore, its impact on AVGO may be limited and indirect. Technical indicators are mixed: the price is slightly above the 20- and 50-day moving averages, RSI is in neutral territory, and MACD is positive but very close to the signal line. The 1.7% decline in the last 24 hours points to short-term weakness. Since the direction of the news is uncertain and does not contain an AVGO-specific catalyst, a neutral trend is expected in the short term.

Piper Sandler's initiation of coverage with a $270 price target implies approximately 13% upside from the current level of $238.54 and could boost buying interest in the short term. Technical indicators also support this view: the price is above the SMA20 and SMA50, MACD is slightly above the signal line, and RSI at 66 is approaching overbought territory. However, the elevated RSI and the 3.4% gain in the last 24 hours bring a risk of short-term profit-taking. Although the news is a positive catalyst, considering the overall market trend and volatility in tech stocks, the upside may be limited. Therefore, I expect a moderate upward bias in the 1-3 day horizon, but investors would do well to watch the $240-245 resistance zone.